Clostridium Difficile Infection Recurrence Clinical Trial
Official title:
A Multi-center, Single-arm Trial Exploring the Safety and Clinical Effectiveness of RBX2660 Administered by Colonoscopy to Adults With Recurrent Clostridioides Difficile Infection
This trial will be initiated to explore whether RBX2660 (REBYOTA®) could be suitable for administration by the practice of colonoscopy. More specifically, the purpose of this trial is to explore the safety and clinical effectiveness of RBX2660 when delivered by colonoscopy to adults with rCDI. The experience of physicians will be documented through a physician-experience questionnaire to explore the usability of RBX2660 in clinical practice for colonoscopic administration. Furthermore, to explore the patient-experience of RBX2660 treatment, each trial participant will be offered to undergo a structured interview.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04000555 -
Oral Vancomycin for Secondary Prophylaxis of Clostridium Difficile Infection (CDI)
|
Phase 4 | |
| Terminated |
NCT03065374 -
Treatment for Clostridium-difficile Infection With IMM529
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT05606159 -
Bacillus Velezensis DSM 33864 for Reduction of the Risk of Recurrent Clostridioides Difficile Infections
|
N/A | |
| Completed |
NCT03110133 -
Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. Diff
|
Phase 2 | |
| Recruiting |
NCT06237452 -
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
|
Phase 3 | |
| Completed |
NCT03880539 -
Bezlotoxumab (BEZLO) In Addition To Standard Of Care (SOC) Vancomycin For The Treatment of Multi-Recurrent Clostridium Difficile Infection
|
Phase 4 | |
| Not yet recruiting |
NCT04415918 -
Bezlotoxumab Efficacy and Tolerability in Cancer Patient
|
Phase 4 | |
| Recruiting |
NCT03562741 -
Outcomes and Data Collection for Fecal Microbiota Transplantation for the Treatment of Recurrent Clostridium Difficile
|
N/A | |
| Completed |
NCT03788434 -
Phase 2 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection
|
Phase 2 | |
| Completed |
NCT04891965 -
A Study of ART24 in Subjects Recently Cured of a Clostridioides Difficile Infection (CDI)
|
Phase 1 | |
| Completed |
NCT04317963 -
Real-world Evaluation of Bezlotoxumab for the Management of Clostridioides Difficile Infection
|
||
| Completed |
NCT03617445 -
Fecal Microbiota Transplantation for C. Difficile Infection in Solid Organ Transplant Recipients
|
Phase 2 |